سعر ايلونفا 150 مكجم/0.5 مل سرنجة معبأة مسبقاً 2022

Elonva 150 mcg/0.5 ml corifollitropin alfa prefilled syringe (MSD). Sheet notes n/a yet for Egyptian availability.

• Controlled ovarian stimulation with a GnRH antagonist for multiple follicular development in women in ART programs; also adolescent males ≥14 years with hypogonadotropic hypogonadism in combination with hCG (EMA Elonva).Population: Women in ART; adolescent males with HHEuropean Medicines Agency

• Women (up to 1/10): headache, nausea, tiredness, pelvic pain/discomfort, breast tenderness, OHSS. Adolescent boys: vomiting, hot flushes, injection-site pain (EMA).International label, same product · European Medicines Agency

• Must not be used with tumours of ovary/breast/womb/pituitary/hypothalamus; abnormal non-menstrual vaginal bleeding of unknown cause; fibroids/malformations preventing pregnancy; primary ovarian failure; enlarged ovaries/cysts; OHSS risk factors including PCOS (EMA overview).International label, same product · European Medicines Agency

• OHSS is an important risk in women; monitor ovarian response. Use only under specialists experienced in fertility or HH treatment (EMA).International label, same product · European Medicines Agency

• Corifollitropin alfa: Corifollitropin alfa is similar to FSH with a peptide that prolongs activity; a single dose is effective for about seven days (EMA overview).